Purine and Pyrrolopyrimidine-Based Small Molecules as Multitarget Therapeutics

Area of Science:

• Medicinal Chemistry
• Drug Design
• Heterocyclic Chemistry

Background:

• Purines and pyrrolo[2,3-d]pyrimidines are privileged scaffolds in drug discovery.
• These scaffolds are known to interact with diverse therapeutic targets.
• Their potential in multitarget drug design is underexplored.

Purpose of the Study:

• To provide a comprehensive overview of purine- and pyrrolopyrimidine-based compounds for multitarget drug design.
• To emphasize design principles and structure-activity relationships (SAR) for simultaneous target modulation.
• To highlight applications in anticancer, anti-inflammatory, and drug resistance therapies.

Main Methods:

• Systematic review of literature on purine and pyrrolopyrimidine compounds over the last two decades.
• Analysis of design principles and SAR for multitarget activity.
• Comparison of compounds across different target classes to identify key structural features.

Main Results:

• Identified key structural features enabling multitarget activity and polypharmacology.
• Demonstrated successful application in developing dual- and multitarget inhibitors.
• Highlighted compounds overcoming drug resistance via simultaneous pathway modulation.

Conclusions:

• Purine and pyrrolopyrimidine scaffolds offer a robust framework for multitarget drug development.
• Specific scaffold modifications can tune potency, selectivity, and polypharmacological profiles.
• Emerging opportunities exist for next-generation polypharmacological agents based on these scaffolds.